Surgical Therapy for Complex Coronary Artery Disease

Seminars in Thoracic and Cardiovascular Surgery

Volumn 21, Issue 3, 2009, Pages 199-206

  ElBardissi, Andrew W ^a   Balaguer, Jorge M ^b   Byrne, John G ^b   Aranki, Sary A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

coronary artery disease; coronary endarterectomy; gene therapy; protein therapy; transmyocardial revascularization

Indexed keywords

ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEFIBRILLATOR; ENDARTERECTOMY; GRAFT PATENCY; HEART CATHETERIZATION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERNAL MAMMARY ARTERY; LABORATORY TEST; LEFT ANTERIOR DESCENDING CORONARY ARTERY; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE PERIOD; PHYSICAL EXAMINATION; THORAX RADIOGRAPHY; TREADMILL EXERCISE;

CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY OCCLUSION; ENDARTERECTOMY; HEART CATHETERIZATION; HUMANS; LASER THERAPY; MYOCARDIAL ISCHEMIA; REOPERATION; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR PATENCY;

EID: 70449704539     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2009.08.006     Document Type: Article

References (76)

1. Al-Mallah M.H., Tleyjeh I.M., Abdel-Latif A.A., et al. Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: A systematic review and meta-analysis of randomized controlled trials. J Am Coll Cardiol 47 (2006) 1576-1583
2. Biondi-Zoccai G.G., Lotrionte M., Agostoni P., et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 27 (2006) 2667-2674
3. SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): A randomised controlled trial. Lancet 360 (2002) 965-970
4. Goy J.J., Eeckhout E., Burnand B., et al. Coronary angioplasty versus left internal mammary artery grafting for isolated proximal left anterior descending artery stenosis. Lancet 343 (1994) 1449-1453
5. Goy J.J., Eeckhout E., Moret C., et al. Five-year outcome in patients with isolated proximal left anterior descending coronary artery stenosis treated by angioplasty or left internal mammary artery grafting. A prospective trial. Circulation 99 (1999) 3255-3259
6. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335 (1996) 217-225
7. King III S.B., Barnhart H.X., Kosinski A.S., et al. Angioplasty or surgery for multivessel coronary artery disease: Comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory angioplasty versus Surgery Trial Investigators. Am J Cardiol 79 (1997) 1453-1459
8. Coronary angioplasty versus medical therapy for angina. The second randomised intervention treatment of angina (rita-2) trial. Rita-2 trial participants. Lancet 350 (1997) 461-468
9. Hamm C.W., Reimers J., Ischinger T., et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI). N Engl J Med 331 (1994) 1037-1043
10. Ferguson Jr. T.B., Hammill B.G., Peterson E.D., et al. A decade of change-Risk profiles and outcomes for isolated coronary artery bypass grafting procedures: A report from the STS National Database Committee and the Duke Clinical, 1990-99 Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg 73 (2002) 480-489 discussion 489-490
11. Ngaage D.L., Griffin S., Guvendik L., et al. Changing operative characteristics of patients undergoing operations for coronary artery disease: Impact on early outcomes. Ann Thorac Surg 86 (2008) 1424-1430
12. Cohn L. Cardiac Surgery in the adult Vol. 3 (2008), McGraw-Hill, New York, NY
13. Lytle B.W., Loop F.D., Taylor P.C., et al. Vein graft disease: The clinical impact of stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg 103 (1992) 831-840
14. Lytle B.W., Loop F.D., Taylor P.C., et al. The effect of coronary reoperation on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg 105 (1993) 605-612 discussion, 612-614
15. Lytle B.W., McElroy D., McCarthy P., et al. Influence of arterial coronary bypass grafts on the mortality in coronary reoperations. J Thorac Cardiovasc Surg 107 (1994) 675-682 discussion, 682-683
16. Perrault L., Carrier M., Cartier R., et al. Morbidity and mortality of reoperation for coronary artery bypass grafting: Significance of atheromatous vein grafts. Can J Cardiol 7 (1991) 427-430
17. Jones E.L., Lattouf O.M., and Weintraub W.S. Catastrophic consequences of internal mammary artery hypoperfusion. J Thorac Cardiovasc Surg 98 (1989) 902-907
18. Jain U., Sullivan H.J., Pifarre R., et al. Graft atheroembolism as the probable cause of failure to wean from cardiopulmonary bypass. J Cardiothorac Anesth 4 (1990) 476-480
19. Navia D., Cosgrove III D.M., Lytle B.W., et al. Is the internal thoracic artery the conduit of choice to replace a stenotic vein graft?. Ann Thorac Surg 57 (1994) 40-43 discussion, 43-44
20. Kamdar A.R., Meadows T.A., Roselli E.E., et al. Multidetector computed tomographic angiography in planning of reoperative cardiothoracic surgery. Ann Thorac Surg 85 (2008) 1239-1245
21. Von Kiedrowski H., Wiemer M., Franzke K., et al. Non-invasive coronary angiography: The clinical value of multi-slice computed tomography in the assessment of patients with prior coronary bypass surgery. Evaluating grafts and native vessels. Int J Cardiovasc Imaging 25 (2009) 161-170
22. Yamamoto M., Kimura F., Niinami H., et al. Noninvasive assessment of off-pump coronary artery bypass surgery by 16-channel multidetector-row computed tomography. Ann Thorac Surg 81 (2006) 820-827
23. Byrne J.G., Aklog L., Adams D.H., et al. Reoperative CABG using left thoracotomy: A tailored strategy. Ann Thorac Surg 71 (2001) 196-200
24. Menasche P., Kural S., Fauchet M., et al. Retrograde coronary sinus perfusion: A safe alternative for ensuring cardioplegic delivery in aortic valve surgery. Ann Thorac Surg 34 (1982) 647-658
25. Gundry S.R., Razzouk A.J., Vigesaa R.E., et al. Optimal delivery of Cardioplegic solution for "redo" operations. J Thorac Cardiovasc Surg 103 (1992) 896-901
26. Rosenberger P., Shernan S.K., Loffler M., et al. The influence of epiaortic ultrasonography on intraoperative surgical management in 6051 cardiac surgical patients. Ann Thorac Surg 85 (2008) 548-553
27. Yau T.M., Borger M.A., Weisel R.D., et al. The changing pattern of reoperative coronary surgery: Trends in 1230 consecutive reoperations. J Thorac Cardiovasc Surg 120 (2000) 156-163
28. Lytle B.W., Loop F.D., Cosgrove D.M., et al. Fifteen hundred coronary reoperations. Results and determinants of early and late survival. J Thorac Cardiovasc Surg 93 (1987) 847-859
29. Loop F.D., Lytle B.W., Cosgrove D.M., et al. Reoperation for coronary atherosclerosis. Changing practice in 2509 consecutive patients. Ann Surg 212 (1990) 378-385 discussion, 385-386
30. Greaves S.C., Rutherford J.D., Aranki S.F., et al. Current incidence and determinants of perioperative myocardial infarction in coronary artery surgery. Am Heart J 132 (1996) 572-578
31. Grinda J.M., Zegdi R., Couetil J.P., et al. Coronary reoperations: Indications, techniques and operative results. Retrospective study of 240 coronary reoperations. J Cardiovasc Surg (Torino) 41 (2000) 703-708
32. He G.W., Acuff T.E., Ryan W.H., et al. Determinants of operative mortality in reoperative coronary artery bypass grafting. J Thorac Cardiovasc Surg 110 (1995) 971-978
33. Weintraub W.S., Jones E.L., Craver J.M., et al. In-hospital and long-term outcome after reoperative coronary artery bypass graft surgery. Circulation 92 suppl (1995) II50-II57
34. Keon W.J., Hendry P., Boyd W.D., et al. Long-term follow-up of coronary endarterectomy. Adv Cardiol 36 (1988) 19-26
35. Livesay J.J., Cooley D.A., Duncan J.M., et al. Early and late results of coronary endarterectomy in 3,369 patients. Adv Cardiol 36 (1988) 27-33
36. Brenowitz J.B., Kayser K.L., and Johnson W.D. Results of coronary artery endarterectomy and reconstruction. J Thorac Cardiovasc Surg 95 (1988) 1-10
37. Goldstein J., Cooper E., Saltups A., et al. Angiographic assessment of graft patency after coronary endarterectomy. J Thorac Cardiovasc Surg 102 (1991) 539-544 discussion, 544-545
38. Beretta L., Lemma M., Vanelli P., et al. Coronary "open" endarterectomy and reconstruction: Short- and long-term results of the revascularization with saphenous vein versus IMA-graft. Eur J Cardiothorac Surg 6 (1992) 382-386 discussion, 387
39. Gill I.S., Beanlands D.S., Boyd W.D., et al. Left anterior descending endarterectomy and internal thoracic artery bypass for diffuse coronary disease. Ann Thorac Surg 65 (1998) 659-662
40. Sundt III T.M., Camillo C.J., Mendeloff E.N., et al. Reappraisal of coronary endarterectomy for the treatment of diffuse coronary artery disease. Ann Thorac Surg 68 (1999) 1272-1277
41. Byrne J.G., Karavas A.N., Gudbjartson T., et al. Left anterior descending coronary endarterectomy: Early and late results in 196 consecutive patients. Ann Thorac Surg 78 (2004) 867-873 discussion, 873-874
42. Zhao D.X., Leacche M., Balaguer J.M., et al. Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. J Am Coll Cardiol 53 (2009) 232-241
43. Rauch E.D., Leach C., Barnes T., et al. Intraoperative assessment and quantification of coronary artery graft patency performed on or off cardiopulmonary bypass. J Extra Corpor Technol 39 (2007) 75-80
44. Sirivella S., Gielchinsky I., and Parsonnet V. Results of coronary artery endarterectomy and coronary artery bypass grafting for diffuse coronary artery disease. Ann Thorac Surg 80 (2005) 1738-1744
45. Tabata M., Shekar P.S., Couper G.S., et al. Early and late outcomes of multiple coronary endarterectomy. J Cardiovasc Surg 23 (2008) 697-700
46. Asimakopoulos G., Taylor K.M., and Ratnatunga C.P. Outcome of coronary endarterectomy: A case-control study. Ann Thorac Surg 67 (1999) 989-993
47. Djalilian A.R., and Shumway S.J. Adjunctive coronary endarterectomy: Improved safety in modern cardiac surgery. Ann Thorac Surg 60 (1995) 1749-1754
48. Shapira O.M., Akopian G., Hussain A., et al. Improved clinical outcomes in patients undergoing coronary artery bypass grafting with coronary endarterectomy. Ann Thorac Surg 68 (1999) 2273-2278
49. Frazier O.H., March R.J., and Horvath K.A. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med 341 (1999) 1021-1028
50. Horvath K.A., Aranki S.F., Cohn L.H., et al. Sustained angina relief 5 years after transmyocardial laser revascularization with a CO(2) laser. Circulation 104 suppl 1 (2001) I81-I84
51. Aranki S.F., Nathan M., and Cohn L.H. Has laser revascularization found its place yet?. Curr Opin Cardiol 14 (1999) 510-514
52. Hattler B.G., Griffith B.P., Zenati M.A., et al. Transmyocardial laser revascularization in the patient with unmanageable unstable angina. Ann Thorac Surg 68 (1999) 1203-1209
53. Allen K.B., Dowling R.D., Fudge T.L., et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med 341 (1999) 1029-1036
54. Burkhoff D., Schmidt S., Schulman S.P., et al. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: A prospective randomised trial. ATLANTIC Investigators. Angina treatments-lasers and normal therapies in comparison. Lancet 354 (1999) 885-890
55. Jones J.W., Schmidt S.E., Richman B.W., et al. Holmium: YAG laser transmyocardial revascularization relieves angina and improves functional status. Ann Thorac Surg 67 (1999) 1596-1601 discussion, 1601-1602
56. Horvath K.A. Results of prospective randomized controlled trials of transmyocardial laser revascularization. Heart Surg Forum 5 (2002) 33-39 discussion, 39-40
57. Aaberge L., Rootwelt K., Blomhoff S., et al. Continued symptomatic improvement three to five years after transmyocardial revascularization with CO(2) laser: A late clinical follow-up of the Norwegian randomized trial with transmyocardial revascularization. J Am Coll Cardiol 39 (2002) 1588-1593
58. Schofield P.M., Sharples L.D., Caine N., et al. Transmyocardial laser revascularisation in patients with refractory angina: A randomised controlled trial. Lancet 353 (1999) 519-524
59. Allen K.B., Dowling R.D., DelRossi A.J., et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: A multicenter, blinded, prospective, randomized, controlled trial. J Thorac Cardiovasc Surg 119 (2000) 540-549
60. Frazier O.H., Tuzun E., Eichstadt H., et al. Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting: A randomized, multicenter study with 4-year follow-up. Tex Heart Inst J 31 (2004) 231-239
61. Wehberg K.E., Julian J.S., Todd III J.C., et al. Improved patient outcomes when transmyocardial revascularization is used as adjunctive revascularization. Heart Surg Forum 6 (2003) 328-330
62. Allen K.B., Dowling R.D., Schuch D.R., et al. Adjunctive transmyocardial revascularization: Five-year follow-up of a prospective, randomized trial. Ann Thorac Surg 78 (2004) 458-465 discussion, 458-465
63. Leung D.W., Cachianes G., Kuang W.J., et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 (1989) 1306-1309
64. Lazarous D.F., Scheinowitz M., Shou M., et al. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 91 (1995) 145-153
65. Banai S., Jaklitsch M.T., Shou M., et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89 (1994) 2183-2189
66. Schumacher B., Pecher P., Von Specht B.U., et al. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease. Circulation 97 (1998) 645-650
67. Simons M., Annex B.H., Laham R.J., et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial. Circulation 105 (2002) 788-793
68. Laham R.J., Sellke F.W., Edelman E.R., et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 100 (1999) 1865-1871
69. Hendel R.C., Henry T.D., Rocha-Singh K., et al. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: Evidence for a dose-dependent effect. Circulation 101 (2000) 118-121
70. Henry T.D., Annex B.H., McKendall G.R., et al. The VIVA trial: Vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 107 (2003) 1359-1365
71. Laham R.J., Rezaee M., Post M., et al. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. J Pharmacol Exp Ther 292 (2000) 795-802
72. Mack C.A., Patel S.R., Schwarz E.A., et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg 115 (1998) 168-176 discussion, 176-177
73. Grines C.L., Watkins M.W., Helmer G., et al. Angiogenic gene therapy (AGENT) trial in patients with stable angina pectoris. Circulation 105 (2002) 1291-1297
74. Grines C.L., Watkins M.W., Mahmarian J.J., et al. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol 42 (2003) 1339-1347
75. Grines C., Rubanyi G.M., Kleiman N.S., et al. Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): A new option for the treatment of coronary artery disease. Am J Cardiol 92 (2003) 24N-31N
76. Hedman M., Hartikainen J., Syvanne M., et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 107 (2003) 2677-2683